Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,344 public trials 3,267 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, not recruiting

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

NCT04444921

Conditions
Anal Basaloid Carcinoma, Anal Canal Carcinoma, Anal Canal Cloacogenic Carcinoma, +18 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 579 locations
View Trial Details
Active, not recruiting

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

NCT04486378

Conditions
Colonic Diseases, Colorectal Cancer Stage II, Colorectal Cancer Stage III, +10 more
Locations
  • Marin Cancer Care Greenbrae, California, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Indianapolis, Indiana, United States
  • Allina Health Minneapolis, Minnesota, United States
  • Oncology Hematology Care Clinical Trials Cincinnati, Ohio, United States
View all 85 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

NCT04449874

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +23 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Chao Family Comprehensive Cancer Center UCI Orange, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 63 locations
View Trial Details
Active, not recruiting

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

NCT02867592

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +92 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 142 locations
View Trial Details
Active, not recruiting

Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study

NCT02997228

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Baldwin Park Baldwin Park, California, United States
View all 445 locations
View Trial Details
Active, not recruiting

Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)

NCT01239082

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Phoenix VA Health Care System, Phoenix, AZ Phoenix, Arizona, United States
  • Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR Little Rock, Arkansas, United States
  • VA Central California Health Care System, Fresno, CA Fresno, California, United States
  • VA Loma Linda Healthcare System, Loma Linda, CA Loma Linda, California, United States
View all 46 locations
View Trial Details
Active, not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT02465060

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1410 locations
View Trial Details
Active, not recruiting

Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)

NCT04379596

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +13 more
Locations
  • Research Site Baltimore, Maryland, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Houston, Texas, United States
View all 71 locations
View Trial Details
Active, not recruiting

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

NCT03233711

Conditions
Anal Basaloid Carcinoma, Anal Canal Carcinoma, Anal Canal Cloacogenic Carcinoma, +16 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 896 locations
View Trial Details

Related conditions